U.S. Stock Night Market Opening Movements

707 rose 24.61% in the night market. Based on recent key news:

1. On July 1, the board of directors of 707 approved the exploration of a digital supply chain platform integrating AI, blockchain traceability, and cryptocurrency payments, causing the stock price to surge 106.30% during intraday trading. This move demonstrates the company's strategic intent in technological innovation, driving a significant increase in stock price. Source: Zhitong Finance

2. On June 30, 707 announced the appointment of Robin Hoksnes Karlsen as executive director, bringing blockchain infrastructure experience, with the stock price soaring over 267% during regular trading hours. This appointment is seen as part of the company's leadership expansion and strategic growth plan, enhancing market confidence. Source: Wall Street Insight

3. On July 1, 707 emphasized that cryptocurrency payment activities require regulatory approval from Hong Kong and the European Union, indicating a coexistence of compliance burdens and market opportunities. This news had a minor impact on the stock price but highlighted the company's cautious attitude in emerging technology fields. Source: Jinshi Data, the industry faces challenges of transparency and sustainability demands.

TNL Mediagene fell 4.82% in the night market. Based on recent key news:

1. On June 29, TNL Mediagene's collaboration with Keychron on the "Keychron Orca echo" keyboard set a GMV record of over 300 million yen on the GIZMART platform, demonstrating strong market demand. However, the company faces the risk of delisting from Nasdaq, with its stock price below $1 and failing to meet shareholder equity requirements, and has applied for a hearing to postpone the delisting process.

2. On June 29, TNL Mediagene issued a statement emphasizing significant uncertainties in its forward-looking statements, which may lead to actual results differing from expectations, increasing market concerns about the company's future performance.

3. On June 30, TNL Mediagene's stock price briefly rose over 100% during intraday trading, but due to delisting risks and market uncertainties, the stock price experienced significant volatility. The market remains vigilant regarding delisting risks, leading to increased fluctuations.

Top Gainers in the U.S. Stock Night Market

SurgePays rose 62.38% in the night market. Based on recent key news:

1. On June 29, SurgePays revised its agreement with ATT Mobility, canceling the remaining $50 million minimum spending commitment. This move significantly improved the company's financial situation, driving the stock price up. Source: Reuters

2. On July 1, the revision of SurgePays' business terms reduced future user costs, enhancing financial stability. This strategic initiative aims to streamline processes and improve financial feasibility, benefiting the company and its stakeholders. Source: Reuters

3. No other significant news recently. The U.S. stock market has seen increased volatility recently, and risks need to be monitored Wheeler Real Estate rose 31.37% in after-hours trading, with no significant news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Gossamer Bio rose 4.29% in after-hours trading. Based on recent news,

1. On July 1, Gossamer Bio announced the initial conversion rate of its 7.50% senior secured convertible notes maturing in 2030 and the initial exercise price of the related warrants. According to the company's announcement, the initial conversion rate of the convertible notes is 5,347.5936 shares of common stock for every $1,000 principal, equivalent to a conversion price of approximately $0.19 per share. The initial exercise price of the warrants is set at $0.34 per share. The above conversion rate and exercise price are calculated based on a reference price determined over seven trading days starting from June 22, 2026, which is $0.17. The conversion rate of the convertible notes is capped at 110% of the reference price, while the exercise price of the warrants is set at 125% of the reference price. Following the announcement, the stock price rose.

2. On July 1, Gossamer Bio set the initial exercise price of its warrants at $0.34 per share. The reference price is $0.17, calculated over seven trading days starting from June 22, 2026. Following the announcement, the stock price rose. The biopharmaceutical industry has been active recently, with significant capital inflow